In an attempt to improve the anti-tumor efficacy of the PEK protein vaccine, we evaluated whether combining inhibition of the PD-L1 immune checkpoint with a PEK protein vaccine could enhance anti-tumor effects in the animal model, and explored the possible mechanisms underlying the strategy. Here, CD274 is linked to neoplasm.